Cited by 481Liver Disease Diagnosis and TreatmentLiver Diseases and ImmunityLiver physiology and pathology

The DOI matches its Crossref record.

Nonalcoholic Steatohepatitis

Elizabeth M. Brunt·2004·Seminars in Liver Disease

DOI 10.1055/s-2004-823098

Open this paper in CoChat — free account

Abstract

Nonalcoholic fatty liver disease (NAFLD) is being increasingly recognized as a common liver disorder that represents the hepatic manifestation of the metabolic syndrome, a variably defined aggregate of disorders related to obesity, insulin resistance, type II diabetes, hypertension and hyperlipidemia. Nonalcoholic steatohepatitis (NASH) is the progressive form of liver injury that carries a risk for progressive fibrosis, cirrhosis, and end-stage liver disease. Hepatocellular carcinoma (HCC) is a documented complication in an as yet unknown percentage of cases of NASH cirrhosis. The diagnosis of nonalcoholic steatohepatitis requires histopathologic evaluation because the lesions of parenchymal injury and fibrosis cannot be detected by imaging studies or laboratory tests. This article will briefly discuss prevalence studies and the pathophysiology of NAFLD and focus on current discussions related to the specific lesions in the pathology of NASH, including the challenges of pediatric NASH and NASH-related cirrhosis.

Integrity signals

Registry

Crossref · 10.1055/s-2004-823098

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 101–200 of 480

Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children
Wang, C., Liang, L., Fu, J., Zou, C., Hong, F., Xue, J.-Z., Lu, J.-R., & Wu, X.-M. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1598 · Cited by 142
The epidemiology of fatty liver
Bellentani, S., Bedogni, G., Miglioli, L., & Tiribelli, C. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200411000-00002 · Cited by 142
The keratin cytoskeleton in liver diseases
Zatloukal, K., Stumptner, C., Fuchsbichler, A., Fickert, P., Lackner, C., Trauner, M., & Denk, H. (2004) · The Journal of Pathology · doi:10.1002/path.1649 · Cited by 140
Evidence for a role of nonalcoholic steatohepatitis in hepatitis C
Bédossa, P., Moucari, R., Chelbi, E., Asselah, T., Paradis, V., Vidaud, M., Cazals-Hatem, D. L., Boyer, N., Valla, D. C., & Marcellin, P. (2007) · Hepatology · doi:10.1002/hep.21711 · Cited by 135
NAFLD prevalence differs among hispanic subgroups: The multi-ethnic study of atherosclerosis
Fleischman, M. W. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i17.4987 · Cited by 134
Diffuse Liver Disease: Strategies for Hepatic CT and MR Imaging
Boll, D. T., & Merkle, E. M. (2009) · Radiographics · doi:10.1148/rg.296095513 · Cited by 134
Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children
Vajro, P., Franzese, A., Valerio, G., et al. (2000) · The Journal of Pediatrics · doi:10.1016/s0022-3476(00)26774-7 · Cited by 134
Mitochondrial glutathione: Hepatocellular survival–death switch
García‐Ruiz, C., & Fernández-Checa, J. C. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04570.x · Cited by 131
Akkermansia muciniphila alleviates high‐fat‐diet ‐related metabolic‐associated fatty liver disease by modulating gut microbiota and bile acids
Wu, W., Kaicen, W., Bian, X., Yang, L., Ding, S., Li, Y., Li, S., Zhuge, A., & Li, L. (2023) · Microbial Biotechnology · doi:10.1111/1751-7915.14293 · Cited by 129
Liver disease in the morbidly obese: A review of 1000 consecutive patients undergoing weight loss surgery
Subichin, M., Clanton, J., Makuszewski, M., Bohon, A., Zografakis, J. G., & Dan, A. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.06.015 · Cited by 124
Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: a randomized, double-blind, placebo controlled trial
Navarro, V. J., Belle, S. H., D’Amato, M., Adfhal, N., Brunt, E. M., Fried, M. W., Reddy, K. R., Wahed, A. S., Harrison, S., & on behalf of the Silymarin in NASH and C Hepatitis (SyNCH) Study Group (2019) · PLoS ONE · doi:10.1371/journal.pone.0221683 · Cited by 125
“Liver biopsy remains the gold standard for diagnosing and assessing the degree of injury in NASH [1,2].”
BackgroundSelf-citation
Biomarker-Based Approaches for Assessing Alcohol Use Disorders
Niemelä, O. J. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13020166 · Cited by 131
Diagnostics and treatment of non-alcoholic fatty liver disease: clinical guidelines of the Russian Scientific Liver Society and the Russian gastroenterological association
Ivashkin, V. T., Mayevskaya, M. V., Pavlov, C. S., Тихонов, И. Н., Shirokova, E. N., Buyeverov, A. O., Drapkina, O. M., Shulpekova, Y. O., Tsukanov, V. V., Mammayev, S. N., et al. (2016) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2016-26-2-24-42 · Cited by 125
Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non‐alcoholic fatty liver disease
Gülşen, M., Yeşilova, Z., Bağcı, S., et al. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03891.x · Cited by 122
Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis
Başkol, G., Başkol, M., & Koçer, D. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.02.006 · Cited by 121
Review article: diagnosis and treatment of non‐alcoholic fatty liver disease
OH, M. K., Winn, J., & Poordad, F. F. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03752.x · Cited by 120
Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease
Kaneda, H., Hashimoto, E., Yatsuji, S., Tokushige, K., & Shiratori, K. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04447.x · Cited by 116
Hepatotoxicity of the thiazolidinediones
Tolman, K. G., & Chandramouli, J. C. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00020-5 · Cited by 115
Hepatic ATP reserve and efficiency of replenishing comparison between obese and nonobese normal individuals
Nair, S. P., Chacko, V. P., Arnold, C., & Diehl, A. M. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07221.x · Cited by 113
Combination of N ‐acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non‐alcoholic steatohepatitis
de Oliveira, C. P. M. S., Stefano, J. T., de Siqueira, É. R. F., Silva, L. S., Mazo, D. F. D. C., de Lima, V. M. R., Junior, C. K. F., de Mello, E. S., Souza, F., Rabelo, F., et al. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00215.x · Cited by 109
Inflammatory Mediators of Hepatic Steatosis
Hijona, E., Hijona, L., Arenas, J. I., & Bujanda, L. (2010) · Mediators of Inflammation · doi:10.1155/2010/837419 · Cited by 105
Steatosis in Mice Is Associated with Gender, Folate Intake, and Expression of Genes of One-Carbon Metabolism
Christensen, K. E., Wu, Q. H., Wang, X., Deng, L.-Y., Caudill, M. A., & Rozen, R. R. (2010) · Journal of Nutrition · doi:10.3945/jn.110.124917 · Cited by 107
A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: ‘bile ductular carcinoma’
Kozaka, K., Sasaki, M., Fujii, T., et al. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02735.x · Cited by 102
Elevated Liver Enzymes in Asymptomatic Patients – What Should I Do?
Malakouti, M., Kataria, A., Ali, S., & Schenker, S. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00027 · Cited by 108
Liver CPT1A gene therapy reduces diet‐induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD
Weber, M., Mera, P., Casas, J., Salvador, J., Rodríguez, A., Alonso, S., Sebastián, D., Soler‐Vázquez, M. C., Montironi, C., Recalde, S., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000678r · Cited by 107
Effect of Dietary Advanced Glycation End Products on Mouse Liver
Patel, R. A., Baker, S. S., Liu, W., Desai, S. S., Alkhouri, R. H., Kozielski, R., Mastrandrea, L. D., Sarfraz, A., Cai, W., Vlassara, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035143 · Cited by 105
DNA Methylation in Nonalcoholic Fatty Liver Disease
Hyun, J., & Jung, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218138 · Cited by 99
Genomic aspects of NAFLD pathogenesis
Naik, A., Košir, R., & Rozman, D. (2013) · Genomics · doi:10.1016/j.ygeno.2013.03.007 · Cited by 108
Liver-Specific Deletion of Augmenter of Liver Regeneration Accelerates Development of Steatohepatitis and Hepatocellular Carcinoma in Mice
Gandhi, C. R., Chaillet, J. R., Nalesnik, M. A., Kumar, S., Dangi, A., Demetris, A. J., Ferrell, R. E., Wu, T., Divanovic, S., Stankeiwicz, T., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.10.008 · Cited by 102
Nonalcoholic steatohepatitis: pathologic features and differential diagnosis
Brunt, E. M. (2005) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2006.04.002 · Cited by 100
Self-citation
Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases
Seki, S., Kitada, T., & SAKAGUCHI, H. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.09.020 · Cited by 97
Obesity: An Immunometabolic Perspective
Ray, I., Mahata, S. K., & De, R. K. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00157 · Cited by 107
Recent trend of clinical features in patients with hepatocellular carcinoma
Nagaoki, Y., Hyogo, H., Aikata, H., Tanaka, M., Naeshiro, N., Nakahara, T., Honda, Y., Miyaki, D., Kawaoka, T., Takaki, S., et al. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00929.x · Cited by 94
Top-Down and Bottom-Up Identification of Proteins by Liquid Extraction Surface Analysis Mass Spectrometry of Healthy and Diseased Human Liver Tissue
Sarsby, J., Martin, N. J., Lalor, P. F., Bunch, J., & Cooper, H. J. (2014) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-014-0967-z · Cited by 97
Molecular functions and clinical impact of thyroid hormone-triggered autophagy in liver-related diseases
Chi, H., Tsai, C., Tsai, M.-M., Yeh, C., & Lin, K. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0517-x · Cited by 97
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6−174G/C polymorphism is associated with non-alcoholic steatohepatitis
Carulli, L., Canedi, I., Rondinella, S., Lombardini, S., Ganazzi, D., Fargion, S. R., Palma, M. D., Lonardo, A., Ricchi, M., Bertolotti, M., et al. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.03.005 · Cited by 93
Treatment of nonalcoholic fatty liver disease in children: TONIC trial design
Lavine, J. E., Schwimmer, J. B., Molleston, J. P., Scheimann, A. O., Murray, K. F., Abrams, S. H., Rosenthal, P. J., Sanyal, A. J., Robuck, P. R., Brunt, E. M., et al. (2009) · Contemporary Clinical Trials · doi:10.1016/j.cct.2009.09.001 · Cited by 91
Self-citation
Steatohepatitis in obese individuals
Youssef, W. I., & McCullough, A. J. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0334 · Cited by 92
Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice
Fan, Y., Lu, H., Guo, Y., Zhu, T., Garcia-Barrio, M. T., Jiang, Z., Willer, C. J., Zhang, J., & Chen, Y. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.005 · Cited by 92
Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice #
Bijl, N., Sokolović, M., Vrins, C. L. J., Langeveld, M., Moerland, P. D., Ottenhoff, R., van Roomen, C. P. A. A., Claessen, N., Boot, R. G., Aten, J., et al. (2009) · Hepatology · doi:10.1002/hep.23175 · Cited by 94
Leptin induces increased α2(I) collagen gene expression in cultured rat hepatic stellate cells
Saxena, N. K., Saliba, G., Floyd, J. J., & Anania, F. A. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10494 · Cited by 91
Loss of c-Met accelerates development of liver fibrosis in response to CCl4 exposure through deregulation of multiple molecular pathways
Marquardt, J. U., Seo, D., Gómez-Quiroz, L. E., Uchida, K., Gillen, M. C., Kitade, M., Kaposi-Novák, P., Conner, E. A., Factor, V. M., & Thorgeirsson, S. S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.012 · Cited by 89
Acidic Sphingomyelinase Controls Hepatic Stellate Cell Activation and in Vivo Liver Fibrogenesis
Moles, A., Tarrats, N., Morales, A., Domínguez, M., Bataller, R. A., Caballería, J., García‐Ruiz, C., Fernández-Checa, J. C., & Marı́, M. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091257 · Cited by 89
Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications
Wang, Y., Zhou, M., Lam, K. S. L., & Xu, A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200012 · Cited by 90
Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease
Sumida, Y., Kanemasa, K., Imai, S., Mori, K., Tanaka, S., Shimokobe, H., Kitamura, Y., Fukumoto, K., Kakutani, A., Ohno, T., et al. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1039-2 · Cited by 86
Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation
Patil, D. T., & Yerian, L. M. (2012) · Liver Transplantation · doi:10.1002/lt.23499 · Cited by 84
Diabetes Mellitus and Risk of Hepatocellular Carcinoma
Li, X., Wang, X., & Gao, P. (2017) · BioMed Research International · doi:10.1155/2017/5202684 · Cited by 88
Kupffer Cells Sense Free Fatty Acids and Regulate Hepatic Lipid Metabolism in High-Fat Diet and Inflammation
Diehl, K. L., Vorac, J., Hofmann, K., Meiser, P., Unterweger, I. A., Kuerschner, L., Weighardt, H., Förster, I., & Thiele, C. (2020) · Cells · doi:10.3390/cells9102258 · Cited by 93
Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury†
Zhou, M., Xu, A., Tam, P. K. H., Lam, K. S. L., Chan, L., Hoo, R. L. C., Liu, J., Chow, H., & Wang, Y. (2008) · Hepatology · doi:10.1002/hep.22444 · Cited by 86
Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study
Froylich, D., Corcelles, R., Daigle, C. R., Boules, M., Brethauer, S. A., & Schauer, P. R. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.04.004 · Cited by 83
Serum Oxidative Stress Markers and Lipidomic Profile to Detect NASH Patients Responsive to an Antioxidant Treatment: A Pilot Study
Stiuso, P., Scognamiglio, I., Murolo, M., Ferranti, P., Simone, C. D., Rizzo, M. R., Tuccillo, C., Caraglia, M., Loguercio, C., & Federico, A. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/169216 · Cited by 82
Quantifying hepatic steatosis – more than meets the eye
Levene, A., Kudo, H., Armstrong, M. J., Thursz, M. R., Gedroyc, W. M. W., Anstee, Q. M., & Goldin, R. D. (2012) · Histopathology · doi:10.1111/j.1365-2559.2012.04193.x · Cited by 82
Role of gut microbiota in liver diseases
Miyake, Y., & Yamamoto, K. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01088.x · Cited by 84
Hepatic Steatosis In Patients Undergoing Bariatric Surgery and its Relationship to Body Mass Index and Co-Morbidities
Moretto, M., Kupski, C., Mottin, C. C., Repetto, G., Toneto, M. G., Rizzolli, J., Berleze, D., Brito, C. L. D. S., Casagrande, D. S., & de Paris, F. G. C. (2003) · Obesity Surgery · doi:10.1381/096089203322190853 · Cited by 82
Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease
Méndez‐Sánchez, N., Zamora‐Valdés, D., Pichardo-Bahena, R., Barredo-Prieto, B. A., Ponciano‐Rodríguez, G., Bermejo-Martínez, L., Chávez-Tapia, N. C., González, H. A. B., & Uribe, M. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01401.x · Cited by 82
A Strong Interaction between Serum γ-Glutamyltransferase and Obesity on the Risk of Prevalent Type 2 Diabetes: Results from the Third National Health and Nutrition Examination Survey
Lim, J.-S., Lee, D., Park, J.-Y., et al. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.079814 · Cited by 82
Metabolic, Hormonal, Oxidative, and Inflammatory Factors in Pediatric Obesity-related Liver Disease
Mandato, C., Lucariello, S., Licenziati, M. R., Franzese, A., Spagnuolo, M. I., Ficarella, R., Pacilio, M., Amitrano, M., Capuano, G., Meli, R., et al. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.02.028 · Cited by 81
A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis
Gaidos, J. K. J., Hillner, B. E., & Sanyal, A. J. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01693.x · Cited by 79
Non-alcoholic steatohepatitis
Jansen, P. L. M. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200411000-00001 · Cited by 80
Glutathione metabolism and antioxidant enzymes in patients affected by nonalcoholic steatohepatitis
Nobili, V., Pastore, A., Gaeta, L. M., et al. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.12.022 · Cited by 79
Curcumin ameliorates rabbits's steatohepatitis via respiratory chain, oxidative stress, and TNF-α
Ramírez-Tortosa, M. C., Ramírez-Tortosa, C. L., Mesa, M. D., Granados-Principal, S. M., Gil, Á., & Quiles, J. L. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.015 · Cited by 79
Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease
Guy, C. D., Suzuki, A., Burchette, J. L., Brunt, E. M., Abdelmalek, M. F., Cardona, D. M., McCall, S. J., Ünalp, A., Belt, P. H., Ferrell, L. D., et al. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.07.007 · Cited by 79
Self-citation
Liver Enzymes and Histology in Obese Patients With Obstructive Sleep Apnea
Kallwitz, E. R., Herdegen, J. J., Madura, J., Jakate, S. M., & Cotler, S. J. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225692.62121.55 · Cited by 78
Protective effects of Ginkgo biloba leaf polysaccharide on nonalcoholic fatty liver disease and its mechanisms
Yan, Z., Fan, R., Yin, S., Zhao, X., Liu, J., Li, L., Zhang, W., & Ge, L. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.05.054 · Cited by 79
Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease
Ioannou, G. N., Weiss, N. S., Boyko, E. J., Kahn, S. E., & Lee, S. P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.004 · Cited by 78
Modern approach to the clinical management of non-alcoholic fatty liver disease
Ben, M. D. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8341 · Cited by 78
Imaging of Nonalcoholic Steatohepatitis: Advantages and Pitfalls of Ultrasonography and Computed Tomography
Tobari, M., Hashimoto, E., Yatsuji, S., Torii, N., & Shiratori, K. (2009) · Internal Medicine · doi:10.2169/internalmedicine.48.1869 · Cited by 77
Quantification of Hepatic Steatosis with 3-T MR Imaging: Validation inob/obMice
Hines, C. D. G., Yu, H., Shimakawa, A. S., McKenzie, C. A., WARNER, T. F. C. S., Brittain, J. H., & Reeder, S. B. (2009) · Radiology · doi:10.1148/radiol.09090131 · Cited by 76
Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C
Tanaka, A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i39.5180 · Cited by 76
Nonalcoholic Fatty Liver Disease
Law, K., & Brunt, E. M. (2010) · Clinics in Liver Disease · doi:10.1016/j.cld.2010.07.006 · Cited by 77
Self-citation
Stearoyl-CoA desaturase plays an important role in proliferation and chemoresistance in human hepatocellular carcinoma
Bansal, S., Berk, M. P., Alkhouri, N., Partrick, D. A., Fung, J. J., & Feldstein, A. E. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.07.001 · Cited by 76
Lycopene Prevents Development of Steatohepatitis in Experimental Nonalcoholic Steatohepatitis Model Induced by High-Fat Diet
Bahçecioğlu, İ. H., Kuzu, N., Metin, K., Özercan, İ. H., Üstündağ, B., Şahin, K., & Küçük, Ö. (2010) · Veterinary Medicine International · doi:10.4061/2010/262179 · Cited by 75
Glucocerebroside Ameliorates the Metabolic Syndrome in OB/OB Mice
Margalit, M., Shalev, Z., Pappo, O., Sklair‐Levy, M., Alper, R., Gomori, M. J., Engelhardt, D., Rabbani, E., & Ilan, Y. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104950 · Cited by 75
Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging
Mashhood, A., Railkar, R. A., Yokoo, T., Levin, Y. S., Clark, L., Fox‐Bosetti, S., Middleton, M. S., Riek, J. K., Kauh, E. A., Dardzinski, B. J., et al. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23928 · Cited by 74
How should we manage patients with non‐alcoholic fatty liver disease in 2007?
Chan, H. L., de Silva, H. J., Leung, N. W. Y., Lim, S. G., Farrell, G. C., & NAFLD, T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04977.x · Cited by 74
Role of hepatic iron in non‐alcoholic steatohepatitis
Sumida, Y., Yoshikawa, T., & Okanoue, T. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00442.x · Cited by 71
Neutrophil depletion improves diet-induced non-alcoholic fatty liver disease in mice
Ou, R., Liu, J., Lv, M., Wang, J., Wang, J., Zhu, L. Y., Zhao, L., & Xu, Y. (2017) · Endocrine · doi:10.1007/s12020-017-1323-4 · Cited by 73
Paediatric fatty liver disease (PeFLD): All is not NAFLD – Pathophysiological insights and approach to management
Hegarty, R., Deheragoda, M. G., Fitzpatrick, E., & Dhawan, A. K. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.02.006 · Cited by 75
Effect of Roux-en-y Gastric Bypass on Nonalcoholic Fatty Liver Disease Evaluated Through NAFLD Fibrosis Score: a Prospective Study
Cazzo, E., Jimenez, L. S., Pareja, J. C., & Chaim, E. A. (2015) · Obesity Surgery · doi:10.1007/s11695-014-1489-2 · Cited by 72
Genome-wide transcriptome analysis identifies novel gene signatures implicated in human chronic liver disease
Smalling, R. V., Delker, D. A., Zhang, Y., Nieto, N., McGuiness, M., Liu, S., Friedman, S. L., Hagedorn, C. H., & Wang, L. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00077.2013 · Cited by 72
Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
Wang, X., Cao, Y., Fu, Y., Guo, G., & Zhang, X. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-234 · Cited by 72
Histological progression of non‐alcoholic fatty liver disease: a critical reassessment based on liver sampling variability
Ratziu, V., Bugianesi, E., Dixon, J. B., Fassio, E., Ekstedt, M., Charlotte, F., Kechagias, S., Poynard, T., & Olsson, R. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03425.x · Cited by 70
Sinusoidal Obstruction Syndrome Is a Major Feature of Hepatic Lesions Associated with Oxaliplatin Neoadjuvant Chemotherapy for Liver Colorectal Metastases
Rubbia‐Brandt, L., Mentha, G., & Terris, B. (2005) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2005.09.010 · Cited by 71
Cytokeratin 18, Alanine Aminotransferase, Platelets and Triglycerides Predict the Presence of Nonalcoholic Steatohepatitis
Cao, W. J., Zhao, C., Shen, C., & Wang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082092 · Cited by 70
Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer
Matsuo, K., Gualtieri, M. R., Cahoon, S. S., Jung, C. E., Paulson, R. J., Shoupe, D., Muderspach, L. I., Wakatsuki, A., Wright, J. D., & Roman, L. D. (2015) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000500 · Cited by 71
Oxidative markers, nitric oxide and homocysteine alteration in hypercholesterolimic rats: role of atorvastatine and cinnamon.
Amin, K. A., & El-Twab, T. M. A. (2009) · PubMed Central · Cited by 71
High gastrointestinal permeability and local metabolism of naringenin: influence of antibiotic treatment on absorption and metabolism
Orrego-Lagarón, N., Martínez‐Huélamo, M., Vallverdú‐Queralt, A., Lamuela-Raventós, R. M., & Escribano‐Ferrer, E. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515001671 · Cited by 70
Epidemiology of non‐alcoholic fatty liver disease‐related hepatocellular carcinoma and its implications
Wong, S.-W., Ting, Y.-W., & Chan, W. (2018) · JGH Open · doi:10.1002/jgh3.12070 · Cited by 58
Restriction of dietary calories, fat and iron improves non‐alcoholic fatty liver disease
Yamamoto, M., Iwasa, M., Iwata, K., Kaito, M., Sugimoto, R., Urawa, N., Mifuji, R., Konishi, M., Kobayashi, Y., & Adachi, Y. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04548.x · Cited by 68
Review article: the metabolic syndrome and non‐alcoholic fatty liver disease
LORIA, P., Lonardo, A., Carulli, L., VERRONE, A. M., Ricchi, M., Lombardini, S., Rudilosso, A., Ballestri, S., & Carulli, N. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02592.x · Cited by 65
Non‐alcoholic fatty liver disease – histological scoring systems: a large cohort single‐center, evaluation study
Rastogi, A., Shasthry, S. M., Agarwal, A., et al. (2017) · Apmis · doi:10.1111/apm.12742 · Cited by 65
“Let There Be Bile”‐Understanding Hepatic Injury in Cholestasis
Sokol, R. J., Devereaux, M. W., Dahl, R., et al. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000226384.71859.16 · Cited by 64
Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
Chagas, A. L., Kikuchi, L., de Oliveira, C. P. M. S., Paranaguá‐Vezozzo, D. C., de Mello, E. S., de Oliveira, A. C. S., Cella, L. C., Herman, P., Bacchella, T., Caldwell, S. H., et al. (2009) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2009005000019 · Cited by 64
CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice
Bian, Z., Peng, Y., You, Z., Wang, Q., Miao, Q., Liu, Y., Han, X., Qiu, D., Li, Z., & Ma, X. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m026013 · Cited by 64
Review article: drug therapy for non‐alcoholic fatty liver disease
Comar, K. M., & Sterling, R. K. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02751.x · Cited by 65
Non-alcoholic fatty liver: a common manifestation of a metabolic disorder
Malnick, S. D. H., Beer-Gabel, M., & Knobler, H. (2003) · QJM · doi:10.1093/qjmed/hcg120 · Cited by 62
The Role of Mitochondrial Adaptation and Metabolic Flexibility in the Pathophysiology of Obesity and Insulin Resistance: an Updated Overview
Tsilingiris, D., Tzeravini, E., Koliaki, C. C., Dalamaga, Μ., & Kokkinos, A. D. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00434-0 · Cited by 60
“A crucial transitional step towards advanced NAFLD is that of non-alcoholic steatohepatitis (NASH), which denotes the presence of hepatocellular necro-inflammation with or without liver enzyme elevations [113, 114].”
Background
Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease
Heebøll, S. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i4.188 · Cited by 60
Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis
Marcolin, É., Forgiarini, L. F., Tieppo, J., Dias, A. S., de Freitas, L. A. R., & Marroni, N. P. (2011) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032011000100015 · Cited by 61
Liver biopsy in elevated liver functions tests? An old question revisited
Bianchi, L. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00155-6 · Cited by 57

Authors: Brunt, E. M.
Affiliations: Saint Louis University Hospital (US)
Corresponding author: Elizabeth M. Brunt
ORCID: Elizabeth M. Brunt
Venue: Seminars in Liver Disease
Publisher: Georg Thieme Verlag KG
Published: 2004-01
Volume: 24
Issue: 1
Pages: 3-20
ISSN: 0272-8087 (ISSN-L)
1098-8971
DOI: 10.1055/s-2004-823098
OpenAlex: W3149847267
Cited by: 481
References: 0
Citations by year: 2026: 2 · 2025: 2 · 2024: 9 · 2023: 8 · 2022: 4 · 2021: 6 · 2020: 13 · 2019: 4 · 2018: 18 · 2017: 14 · 2016: 24 · 2015: 25 · 2014: 26 · 2013: 22 · 2012: 31
FWCI: 29.48
Type: journal article
Language: en
Open access: closed
Locations: Seminars in Liver Disease (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, metabolic syndrome, liver fibrosis, liver cirrhosis, hepatocellular carcinoma, histopathology, pathophysiology, prevalence, insulin resistance, obesity
MeSH terms: Adolescent, Adult, Child, Fatty Liver, Fatty Liver, Alcoholic, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Liver Neoplasms, Prevalence, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nonalcoholic Steatohepatitis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks